Evidence map›Paper›PMID 37376114›Full record

ArticlePharmaceutics2023

Synthesis, Characterization, and Docking Study of Novel Thioureidophosphonate-Incorporated Silver Nanocomposites as Potent Antibacterial Agents.

Ahmed I El-Tantawy, Elshaymaa I Elmongy, Shimaa M Elsaeed, Abdel Aleem H Abdel Aleem, Reem Binsuwaidan, Wael H Eisa, Ayah Usama Salman, Noura Elsayed Elharony, Nour F Attia

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ahmed I El-TantawyDepartment of Chemistry, Faculty of Science, Menoufia University, Shibin El Kom 32511, Egypt.
Elshaymaa I ElmongyDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0003-1160-5040
Shimaa M ElsaeedDepartment of Analysis and Evaluation, Egyptian Petroleum Research Institute, Cairo 11727, Egypt.
Abdel Aleem H Abdel AleemDepartment of Chemistry, Faculty of Science, Menoufia University, Shibin El Kom 32511, Egypt.
Reem BinsuwaidanDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0003-1406-282X
Wael H EisaSpectroscopy Department, Physics Division, National Research Centre (NRC), Cairo 12622, Egypt.
Ayah Usama SalmanDepartment of Botany and Microbiology, Faculty of Science, Menoufia University, Shibin El Kom 32511, Egypt.
Noura Elsayed ElharonyDepartment of Chemistry, Faculty of Science, Menoufia University, Shibin El Kom 32511, Egypt.
Nour F AttiaGas Analysis and Fire Safety Laboratory, Chemistry Division, National Institute for Standards, 136, Giza 12211, Egypt.ORCID 0000-0002-0713-1738

Funding

Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2023R304)‎
6 · The paper itself

Abstract

Newly synthesized mono- and bis-thioureidophosphonate (MTP and BTP) analogues in eco-friendly conditions were employed as reducing/capping cores for 100, 500, and 1000 mg L

Indexed as

antibacterialantibiofilmantifoulingbactericidalmolecular dockingsilver nanocompositesthioureidophosphonates

Identifiers

PMID37376114
PMCPMC10304937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.